Dose Ranging Study of Magnesium Iron Hydroxycarbonate in Haemodialysis Subjects With Hyperphosphataemia
Status:
Completed
Trial end date:
2008-04-01
Target enrollment:
Participant gender:
Summary
Magnesium iron hydroxycarbonate is a phosphate binder that absorbs phosphate from food,
reducing the amount that the body can absorb.
The purpose of this study is to determine how well a range of different doses of fermagate
are tolerated by the subjects in the trial.